AnheuserBusch InBev (BUD)
(Delayed Data from NYSE)
$59.30 USD
-0.07 (-0.12%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $59.30 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth A Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$59.30 USD
-0.07 (-0.12%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $59.30 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth A Momentum B VGM
Zacks News
AB InBev (BUD) Q1 Earnings Miss Estimates, Revenues Beat
by Zacks Equity Research
AB InBev (BUD) Q1 results reflect gains from robust revenue per hectoliter (hl) growth, pricing actions and revenue management initiatives.
Q1 Earnings Season Scorecard and Featured Research on Apple, Microsoft & Meta Platforms
by Sheraz Mian
Today's Research Daily features the Q1 earnings season scorecard and new research reports on Apple (AAPL), Microsoft (MSFT), Meta Platforms. (META) and others.
AB InBev (BUD) to Report Q1 Earnings: What's on the Cards?
by Zacks Equity Research
AB InBev's (BUD) Q1 results are expected to reflect gains from premiumization efforts, expansion of the beyond beer portfolio and digital initiatives, offset by elevated costs and currency headwinds.
Zacks Industry Outlook Highlights AnheuserBusch InBev, Constellation Brands, Brown-Forman, Molson Coors and The Duckhorn Portfolio
by Zacks Equity Research
AnheuserBusch InBev, Constellation Brands, Brown-Forman, Molson Coors and The Duckhorn Portfolio are part of the Zacks Industry Outlook article.
5 Stocks Poised to Benefit From Favorable Alcohol Industry Trends
by Rajani Lohia
The Beverages - Alcohol industry looks poised for growth on favorable demand trends, innovation, diversification, premiumization and digital growth amid elevated input and packaging costs. Players like BUD, STZ, BF.B, TAP and NAPA will likely capitalize.
4 Stocks to Watch on Dividend Hikes as Inflation Softens
by Zacks Equity Research
Investors may keep a tab on stocks like AON, ST, TRGP and BUD, which have lately hiked their dividend payments.
Brown-Forman (BF.B) Q3 Earnings Miss, Sales Top Estimates
by Zacks Equity Research
Brown-Forman's (BF.B) Q3 results reflect gains from a strong top line on strength in its brands, premiumization and growth across regions. Soft operating income hurt the bottom line.
Are Investors Undervaluing AnheuserBusch InBev (BUD) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
BUD or DEO: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
BUD vs. DEO: Which Stock Is the Better Value Option?
AB InBev (BUD) Q4 Earnings Surpass Estimates, Revenues Miss
by Zacks Equity Research
AB InBev (BUD) Q4 results gain from improved sales, continued business momentum, strong demand for its portfolio and investment in brands.
Here's How AB InBev (BUD) Looks Just Ahead of Q4 Earnings
by Zacks Equity Research
AB InBev (BUD) Q4 results are expected to reflect gains from continued business momentum, premiumization and digital growth, offset by adverse currency rates, commodity costs and supply-chain costs.
Are Consumer Staples Stocks Lagging AnheuserBusch InBev (BUD) This Year?
by Zacks Equity Research
Here is how Anheuser-Busch Inbev (BUD) and Altria (MO) have performed compared to their sector so far this year.
BUD or DEO: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
BUD vs. DEO: Which Stock Is the Better Value Option?
The Zacks Analyst Blog Highlights Compania Cervecerias Unidas, Kirin Holdings and Anheuser-Busch InBev
by Zacks Equity Research
Compania Cervecerias Unidas, Kirin Holdings and Anheuser-Busch InBev are part of the Zacks top Analyst Blog.
Coca-Cola (KO) Q4 Earnings Meet Estimates, Revenues Beat
by Zacks Equity Research
Coca-Cola's (KO) Q4 results reflect gains from strong revenue growth across its operating segments, aided by an improved price/mix and increased concentrate sales.
Alcohol Companies Are Looking Out to a Strong 2023
by Sejuti Banerjea
With supply chains easing and demand, especially for premium products remaining strong, alcohol stocks are likely to see a strong year ahead.
Market Awaits CPI Numbers Due Next Week
by Zacks Equity Research
Market Awaits CPI Numbers Due Next Week.
Should You Invest in Super Bowl Weekend?
by Mark Vickery
Super Bowl LVII is this Sunday, with the Kansas City Chiefs and the Philadelphia Eagles vying for the championship.
Is AnheuserBusch InBev (BUD) Stock Outpacing Its Consumer Staples Peers This Year?
by Zacks Equity Research
Here is how Anheuser-Busch Inbev (BUD) and Lamb Weston (LW) have performed compared to their sector so far this year.
BUD or DEO: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
BUD vs. DEO: Which Stock Is the Better Value Option?
Diageo (DEO) 1H FY23 Earnings & Sales Rise on Strong Demand
by Zacks Equity Research
Diageo's (DEO) first-half fiscal 2023 results reflect gains from its strong premium portfolio, growth across all regions and favorable industry trends, which aid sales and the organic operating margin.
Procter & Gamble (PG) Beats Q2 Earnings & Sales Estimates
by Zacks Equity Research
Procter & Gamble (PG) Q2 results reflect gains from robust pricing and a favorable mix, mostly offset by elevated commodity and input costs, and currency headwinds.
The Zacks Analyst Blog Highlights Nike, Novartis, Wells Fargo, Broadcom and Anheuser-Busch
by Zacks Equity Research
Nike, Novartis, Wells Fargo, Broadcom and Anheuser-Busch are part of the Zacks top Analyst Blog.
Why is Molson Coors (TAP) an Attractive Option for the Long Run?
by Zacks Equity Research
Molson Coors (TAP) looks poised for growth on the back of its innovation and premiumization efforts, revitalization plan, and improved pricing.
Top Stock Reports for NIKE, Novartis & Wells Fargo
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including NIKE, Inc. (NKE), Novartis AG (NVS) and Wells Fargo & Company (WFC).